Oncotelic Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.09	0.09	0.17	0.24	0.57
Cash & Short-Term Investments	0.09	0.09	0.17	0.24	0.57
Cash Growth	3.17%	-49.46%	-29.43%	-57.55%	19.99%
Accounts Receivable	-	-	0.02	-	-
Other Receivables	0.05	0.02	-	0.02	0.02
Receivables	0.05	0.02	0.02	0.02	0.02
Prepaid Expenses	1.04	0.01	0.06	0.02	0.02
Restricted Cash	0.02	0.02	0.02	0.02	0.02
Total Current Assets	1.2	0.13	0.27	0.3	0.63
Long-Term Investments	388	22.65	22.65	22.64	-
Goodwill	2.79	2.79	5.99	12.07	21.06
Other Intangible Assets	-	-	-	-	0.82
Long-Term Deferred Charges	1.1	1.1	1.1	1.1	1.1
Total Assets	393.09	26.68	30.01	36.12	23.61
Accounts Payable	1.64	1.69	1.66	1.74	1.93
Accrued Expenses	1.28	1.09	1.12	1.11	1.57
Short-Term Debt	12.25	13.09	10.68	11.26	8.99
Other Current Liabilities	2.98	3.33	3.05	2.82	2.97
Total Current Liabilities	18.14	19.2	16.5	16.92	15.45
Long-Term Debt	1.66	-	1.9	-	-
Long-Term Deferred Tax Liabilities	111.55	-	-	-	-
Total Liabilities	131.36	19.2	18.4	16.92	15.45
Common Stock	4.43	4.07	3.99	3.92	3.75
Additional Paid-In Capital	47.1	42.22	41.66	41.42	35.22
Retained Earnings	211.24	-38.04	-33.52	-25.93	-31.02
Total Common Equity	262.76	8.25	12.13	19.41	7.96
Minority Interest	-1.03	-0.77	-0.52	-0.22	0.2
Shareholders' Equity	261.73	7.48	11.61	19.19	8.16
Total Liabilities & Equity	393.09	26.68	30.01	36.12	23.61
Total Debt	13.91	13.09	12.57	11.26	8.99
Net Cash (Debt)	-13.82	-13	-12.4	-11.02	-8.42
Net Cash Per Share	-0.03	-0.03	-0.03	-0.02	-0.03
Filing Date Shares Outstanding	444.2	408.29	399.68	392.87	378.63
Total Common Shares Outstanding	442.6	407.29	399.18	391.85	375.29
Working Capital	-16.95	-19.07	-16.23	-16.62	-14.83
Book Value Per Share	0.59	0.02	0.03	0.05	0.02
Tangible Book Value	259.97	5.46	6.14	7.34	-13.93
Tangible Book Value Per Share	0.59	0.01	0.02	0.02	-0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.